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t is well established that individuals with insulin resistance or the metabolic syndrome and type 2 diabetes are at high risk of cardiovascular disease. 1 Oversecretion of triacylglycerol (TG)-rich apolipoprotein B (apoB)-containing lipoproteins, chylomicrons from the intestine and very low-density lipoproteins (VLDL) from the liver contributes to the observed cardiovascular complications. The synthesis of secretion-competent apoB lipoproteins requires coordinated synthesis of lipids (TG, phospholipids, cholesterol, and cholesteryl esters [CE] ) and a growing number of cellular factors that assist transfer of these lipids onto apoB protein, both cotranslationally and posttranslationally. The current model of chylomicron and VLDL assembly proposes a 2-step process. [2] [3] [4] [5] [6] In the first step, newly synthesized apoB is lipidated during its translocation across the endoplasmic reticulum (ER) into the lumen yielding a primordial apoB particle. In the second step, bulk transfer of core lipids from lumenal lipid droplets (LDs) to the primordial apoB particle is believed to take place posttranslationally. However, several outstanding questions remain unanswered regarding the synthesis of lumenal LDs, the mechanism of bulk lipidation of primordial apoB particle and the cellular location of this process.
synthesis of Lumenal Lds evidence for the existence of Lumenal Lds in Lipoprotein Producing Cells
Accumulation of apoB-free lumenal LDs of VLDL size were first observed in the smooth ER of rat hepatocytes by electron microscopy. 7 Lumenal chylomicron-size LDs were also visualized within the ER compartment in apoB deficient mouse enterocytes. 8 Importantly, these lumenal LDs did not appear to egress beyond the ER compartment, 8 which makes teleological sense, because if they did they would be expected to be secreted out of the cell in a similar manner as lipoprotein particles.
synthesis of tG on the er
TG is synthesized on the ER from diacylglycerol and acylcoenzyme A (CoA) by diacylglycerol acyltransferases 1 and 2.
9,10 There has been some debate about the topology of the oligomeric diacylglycerol acyltransferases 1, with 2 reports suggesting either lumenal 11 or both lumenal and cytosolic 12 orientations of the active site. Although the lumenal topology of TG synthesis would not pose any problems for diacylglycerol, a lipid that can readily flip-flop within the membrane bilayer, this location would necessitate the presence of an acyl-CoA flippase on the ER because acyl-CoA is synthesized on the cytosolic face of the ER and cannot freely translocate across the bilayer. Because lumenal acylCoA-dependent acylations do occur in the ER, such as ethanol esterification 13 and apoB palmitoylation, [14] [15] [16] some transporter/ channel-mediated process is likely to exist. To this effect, both N-ethylmaleimide-sensitive acyl-CoA acyltransferasemediated 17, 18 and N-ethylmaleimide insensitive but mersalyl 20 Although a plethora of studies have dealt with the mechanism of cytosolic LD formation and composition, [21] [22] [23] [24] information on the biosynthesis of lumenal LDs is limited in comparison. A number of factors potentially regulating formation of cytosolic LDs have been identified, including perilipins 25 and fat storage-inducing transmembrane proteins. 26 The budding of LDs from the ER into cytosolic or lumenal compartment might also be assisted by local accumulation of charged lipids (phosphatidic acid, lysophosphatidic acid, and phosphoinositides) and lipids with small headgroups (diacylglycerol, phosphatidylethanolamine [PE] ) that can induce membrane curvature and recruit various protein cofactors. 24 The directionality of LD budding (cytosol versus lumen) is probably regulated in part by the presence of specific LD-coat proteins of the perilipin family that decorate cytosolic LDs 25, 27, 28 and by microsomal triglyceride transfer protein (MTP) 29 that has been demonstrated to be essential for the formation of both apoB-containing lipoproteins and lumenal LDs (Figure 1 ).
role of MtP in Lumenal Ld (apoB and non-apoB) Biogenesis
MTP is a soluble lumenal protein localized to the ER 29 but is also shown to traffic to the Golgi. 30 MTP forms a heterodimer with protein disulfide isomerase, 31 a protein that contains an ER retrieval signal, which should ensure return of the MTP/ protein disulfide isomerase complex from the Golgi back to the ER by the KDEL receptor-mediated mechanism. 32, 33 The physiological significance of MTP cycling between the ER and the Golgi is not entirely clear. It has been suggested that VLDL maturation might occur in the Golgi, [34] [35] [36] though the presence of fully lipidated VLDL in the ER has also been reported. 37, 38 MTP is present in all cells that have the capacity to synthesize apoB-containing lipoproteins, including hepatocytes, enterocytes, cardiomyocytes, [39] [40] [41] and kidney tubular epithelial cells, 42 but has also been shown to be expressed in nonlipoprotein producing cells such as white and brown adipocytes. 43 MTP plays an essential role in the assembly of VLDL, aiding cotranslational phospholipid, TG, and CE recruitment by apoB. [44] [45] [46] [47] In addition to its function in the formation of the secretion-competent LDs (apoB lipoproteins), MTP activity is also crucial for the biogenesis of lumenal non-apoB LDs. Liver-specific ablation of Mttp expression resulted in the attenuation of VLDL secretion but also in the abrogation of non-apoB lumenal LD formation. 48 MTP inhibition studies in primary hepatocytes 49 and hepatoma cells 50 further confirmed the requirement of MTP for the accumulation of non-apoB associated neutral lipids within the lumen of microsomal fractions.
Cytosolic Ld-associated Proteins influencing Lumenal Ld Biogenesis/VLdL secretion
Interestingly, factors that regulate cytosolic lipid storage also appear to influence lumenal lipid metabolism. For instance, overexpression of a cytosolic LD-coat perilipin 2 (formerly known as adipocyte differentiation-related protein) promotes cytosolic TG storage and at the same time inhibits VLDL secretion from rat hepatoma cells, and conversely, knock down of perilipin 2 expression augments VLDL secretion. 51 It thus appears that MTP and perilipin 2 compete for the same pool of TG synthesized on the ER and that perilipin 2 depletes lipid availability for lumenal LD formation and apoB assembly, a process that is catalyzed by MTP. This hypothesis also finds support in the observed TG accumulation in liver microsomes prepared from perilipin 2 deficient mice. 52 Another cytosolic LD-associated protein cell death-inducing DFFA-like effector B (CideB) has been shown to influence VLDL maturation. 53, 54 Intriguingly, whereas CideB deficiency reduces VLDL-TG secretion and increases cytosolic TG storage, microsomal TG levels are not changed. 53 In addition, apoB secretion from CideB deficient hepatocytes is not affected, indicating sufficient ER lipid availability for MTP-mediated lipidation of apoB that is necessary for generating secretioncompetent VLDL. The mechanism of CideB-mediated regulation of apoB lipidation is not yet clear, but the data suggest that the protein could function downstream of MTP. It is enticing to speculate that CideB could be the verapamil-sensitive factor that was proposed to facilitate transfer of TG from the cytosol across the ER. 55 Comparative gene identification 58 (CGI-58) (also known as ABHD5), a cofactor required for the activation of a cytosolic adipose triglyceride lipase (ATGL), has also been implicated in apoB-lipoprotein assembly. Depletion of CGI-58 resulted in decreased VLDL secretion from rat hepatoma cells, 56 whereas overexpression of CGI-58 augmented VLDL secretion. 57 The mechanism is not entirely clear because overexpression or ablation of hepatic ATGL has no effect on VLDL secretion (see below). In addition to its cytosolic LD-localization and ATGL colipase function, CGI-58 also associates with the ER/ Golgi compartments 57 and catalyzes CoA-dependent acylation of lysophosphatidic acid to phosphatidic acid. 58, 59 It is not clear which of the 2 functions of CGI-58 (colipase role for a yet uncharacterized lipase or the acyltransferase activity) is important for VLDL assembly, but it is possible that a signaling cascade triggered by phosphatic acid generated by CGI-58 influences VLDL assembly.
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Protein and Lipid Composition of Lumenal Lds
Studies on protein and lipid compositions of cytosolic LDs [61] [62] [63] and apoB-containing lipoproteins within the ER 37,50,64 suggest similarity in major lipid composition with phosphatidylcholine (PC) as the major phospholipid, and TG and CE as core lipids but understandably different protein composition, as expected from the different subcellular localization of these 2 LDs. The proteome and lipidome of non-apoB lumenal LDs from mice have also been determined. 65 The lumenal LDs (apoB and non-apoB) were released from isolated microsomes by a method used for the purification of MTP, 66 apoB-containing particles were immunodepleted and lumenal LDs were isolated by density centrifugation. Whereas TG in mouse cytosolic LDs accounts for up to 80% of total lipids, phospholipid for about 15%, and cholesterol with CE for the remaining 5%, the lumenal LDs contained a lower percentage of TG (60%) and a higher percentage of phospholipid (25%) 65 ; similar lipid ratios were found in mature VLDL. However, the lumenal LDs were found to be heterogeneous in size, possibly reflecting the various states of synthesis/turnover. 65 Proteomic analysis of lumenal LDs revealed presence of MTP, protein disulfide isomerase, apolipoprotein E (apoE), and several other ER resident proteins including 2 members of the carboxylesterase family, carboxylesterase-3/triacylglycerol hydrolase (Ces3/TGH) and carboxylesterase1/esterase-x (Ces1/Es-x). 65 Interestingly, MTP and Ces3/TGH were found on smaller LDs, whereas apoE was associated with larger LDs. 65 ApoE is also a major constituent of VLDL and chylomicron particles. ApoE overexpression promotes VLDL assembly and secretion 67, 68 and apoE deficiency diminishes VLDL secretion, 67 but the underlying mechanism is unclear. ApoE and Ces3/TGH have been shown to physically interact 65 and an attractive hypothesis is that apoE could act as a cofactor (colipase) for Ces3/TGH-mediated lipid hydrolysis. Additional proteins with lipid binding capacity, such as other exchangeable apolipoproteins (eg, apoCIII, and apoAV) have been shown to modulate VLDL assembly. 6 These proteins would be expected to be transiently present in the ER lumen and could therefore become associated either with lumenal LDs or primordial apoB particles or both.
role of Lumenal Lds in Lipoprotein assembly
Fusion Model of VLdL and Chylomicron assembly
Experimental evidence suggests that the addition of bulk TG (presumably from lumenal LDs) to the apoB primordial particle is MTP-independent, 69 thus eliminating vectorial transfer of individual lipid molecules from lumenal LDs to the nascent apoB lipoprotein. A fusion model of lumenal LDs with primordial apoB particles as a mechanism of VLDL assembly has been repeatedly cited in reviews and original research articles, however, convincing experimental evidence that would support such constitutive LD fusion processes in normal physiological conditions is lacking. In fact, fusion of cytosolic LDs is believed to occur very rarely, requiring either an increase in the fusogenic PE (ie, decreased PC/PE ratio) 70 or phosphatidic acid 71 in the surface monolayer of LDs or the assistance of chemical fusogens. 72 Specific Rabs and soluble N-ethylmaleimide-sensitive factor attachment protein receptors have been reported to facilitate the fusion of cytosolic LDs, 73 however these proteins or other proteins that would be capable to carry out similar function are absent from the ER lumen. Therefore, it is still unclear whether fusion of primordial apoB with lumenal LDs is possible.
role of Lipolysis/reesterification Cycle in VLdL and Chylomicron assembly
The second step of apoB lipidation could be inhibited by Brefeldin A in rat hepatoma cells 74 or by Pluronic-L81 in intestinal cells. 75, 76 Interestingly, both of these inhibitors also promote cytosolic TG accretion. Brefeldin A inhibits COPIdependent delivery of ATGL to cytosolic LDs, 77, 78 whereas Pluronic-81 might interfere with transfer of TG from cytosol to the ER. 76 Intriguingly, Pluronic-L81 (a nonionic detergent) may alter LD surface composition and interfere with interfacial activation of lipases that hydrolyze lipids stored within the LDs (cytosolic or lumenal). A link between lipolysis and apoB-lipoprotein assembly is well established. It has been experimentally demonstrated that the majority (60%-80%) of VLDL-TG secreted from primary rat hepatocytes is derived from lipolysis and re-esterification of preformed TG. [79] [80] [81] Similarly, preformed TG in the intestine have been shown to be hydrolyzed to 2-monoacylglycerol before re-esterification of this lipid to TG and incorporation into chylomicrons. 82 The mobilization (lipolysis) of stored cytoplasmic TG for VLDL assembly was believed not to be catalyzed by the lysosomal (acidic) lipase (LAL). 79 However, recent studies have shown increased TG and cholesterol content in rat hepatocytes after pharmacological inhibition of macrolipophagy or after ablation of expression of the autophagygenes Atg5 or Atg7, suggesting a role of autophagy and LAL in the turnover of cytosolic LDs. 83 Liver-specific knockout of Atg7 expression also resulted in 50% decreased TG secretion, therefore implicating autophagy of cytosolic LDs in the provision of substrates for VLDL assembly. 83 On the other hand, genetic ablation of Lal expression in mice did not affect plasma TG and cholesterol/CE levels despite massive intracellular TG and cholesterol/CE accumulation, which suggested that LAL might not play a major role in the plasma lipid homeostasis. 84, 85 Given these seemingly contradicting findings, it will be important to
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address the contribution of LAL to VLDL lipids in depth in the near future. VLDL assembly does not appear to be dependent on hydrolysis of cytosolic TG storage pools by cytosolic lipases ATGL or hormone-sensitive lipase. Overexpression of these lipases in the liver led to diversion of released fatty acids for oxidation, but not for re-esterification and VLDL assembly. 86 Similarly, liver-specific ATGL ablation did not affect VLDL secretion. 87, 88 These results suggest that subcellular localization of the lipase(s) and LDs determine the metabolic fate of the released fatty acids. Because VLDL/chylomicron assembly takes place in the lumen of the ER, lipolysis of lipids in lumenal LDs followed by re-esterification of the lipolytic products by the ER-localized acyltransferases could provide a mechanism for the second step of lipid loading onto nascent apoB-containing particles (Figure 2 ). Lipid hydrolases Ces3/ TGH and Ces1/Es-x are present on the lumenal LDs 65 and several studies have demonstrated that overexpression of Ces3/ TGH increases lipidation of apoB 65, [89] [90] [91] and that inhibition of Ces3/TGH activity reduces VLDL assembly. 92, 93 Phospholipid synthesis/turnover is also important for lumenal lipid metabolism and VLDL assembly. An interesting and intriguing result was obtained in the livers of mice in which the synthesis of PC has been decreased by ablation of PE methyltransferase or cytidine -5-triphosphate: phosphocholine cytidylyltransferase a. Attenuation of PC synthesis via either pathway (PE methyltransferase or cytidine-5-triphosphate:phosphocholine cytidylyltransferase a) resulted in reduced assembly and secretion of VLDL 94, 95 and in concomitant cytosolic TG accumulation. 94, 96 It is possible that the increased TG storage in the livers lacking either pathway for PC synthesis is attributable to diminished TG turnover rather than to increased budding of cytosolic LDs. Similarly, decreased VLDL secretion observed in PE methyltransferase and cytidine-5-triphosphate:phosphocholine cytidylyltransferase a deficient mice might also be in part attributable to decreased lipolysis of TG present in lumenal LDs, however, this hypothesis awaits experimental evidence. There are, however, other possible explanations, such as, lack of PC availability resulting in the production of small apoB particles that cannot expand to accommodate additional TG/CE (bulk lipidation). This hypothesis is supported by studies where attenuated expression of phospholipid transfer protein (PLTP) resulted in diminished VLDL production 97 and increased PLTP led to the production of larger VLDL particles. 98 Whether PLTP can catalyze the transfer of PC from lumenal LDs to nascent apoB particles is not known (Figure 2 ). It is important to note that PLTP is a secreted protein and therefore modulates VLDL assembly and size within the secretory pathway (in the ER or post-ER). Fatty acids released from cellular phospholipids by phospholipases have been shown to be incorporated into VLDL-TG. 99 On the other hand, overexpression of hepatic lipase (also a secreted protein like PLTP) that harbors both TG and phospholipase A 1 activities has been reported to decrease lumenal lipid levels and VLDL secretion.
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Outstanding Questions
Several outstanding issues in lumenal lipid metabolism remain to be experimentally determined. Whereas the presence of lumenal LDs has been unequivocally demonstrated, it is still not clear what, if any, components these droplets provide for apoB-lipoprotein assembly, and the mechanism by which this transfer might occur. Another mystery is the source of neutral lipids for the reported post-ER VLDL core expansion given that TG/CE and apoB-free lumenal LDs are synthesized within the ER and apparently only apoB-associated TG/CE is exported to the Golgi. Acyl-CoA-dependent lumenal lipid synthesis also requires further clarification, specifically the mechanism of transfer of acyl-CoA across the ER bilayer. The mechanisms by which of cytosolic LD-associated proteins (perilipin 2, CideB, and CGI-58) and LAL (macrolipophagy) contribute to lumenal lipid metabolism and lipoprotein assembly also remain to be elucidated. 
